BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Fan H, Zi H, Hu H, Li B, Huang J, Luo P, Zeng X. Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019. J Clin Med 2022;11:2817. [PMID: 35628941 DOI: 10.3390/jcm11102817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Miranda-novales G, Flores-moreno K, López-vidal Y, Ponce de León-rosales S, PUCRA Network Members. Limited Therapeutic Options in Mexico for the Treatment of Urinary Tract Infections. Antibiotics 2022;11:1656. [DOI: 10.3390/antibiotics11111656] [Reference Citation Analysis]
2 Yakovlev SV, Suvorova MP. Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review. Terapevticheskii arkhiv 2022;94:1006-1013. [DOI: 10.26442/00403660.2022.08.201775] [Reference Citation Analysis]
3 Petrosillo N, Granata G. Gram Negatives and Antimicrobial Resistance: Two Faces of the Same Coin. JCM 2022;11:5574. [DOI: 10.3390/jcm11195574] [Reference Citation Analysis]
4 Manivasagan P, Khan F, Rajan Dhatchayeny D, Park S, Joe A, Han HW, Seo SH, Thambi T, Giang Phan VH, Kim YM, Kim CS, Oh J, Jang ES. Antibody-targeted and streptomycin-chitosan oligosaccharide-modified gold nanoshells for synergistic chemo-photothermal therapy of drug-resistant bacterial infection. J Adv Res 2022:S2090-1232(22)00190-4. [PMID: 36041689 DOI: 10.1016/j.jare.2022.08.009] [Reference Citation Analysis]